Roohi Kharofa

Dr. Roohi Kharofa


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Childhood Obesity
Verified
Journal Article
Closed access
RKRoohi Kharofa
Roohi Kharofa
HKHeidi J. Kalkwarf
Heidi J. Kalkwarf
JKJane C. Khoury
Jane C. Khoury
Kristen A CopelandKristen A Copeland
Kristen A Copeland
Background: Mealtime best practices for obesity prevention in child care have been developed from experimental studies and expert opinion. Our objective was to describe adherence to best practices in child care centers and to evaluate the association between mealtime practices and children's dietary intake. Methods: We conducted an observational study of 349 preschoolers, ages 36 to 72 months, from 30 child care centers in Cincinnati, Ohio (November 2009 to January 2011). Trained observers recorded providers' behaviors related to six mealtime best practice recommendations and documented children's intake (n = 60 group lunches). General linear mixed models were used to evaluate the association between practice use and children's total energy (caloric consumption) and fruit and vegetable consumption. Results: Adherence to individual mealtime best practices was variable (0%–77%). Staff sitting with children at lunch was associated with lower energy intake and higher vegetable intake. Staff eating some of the same foods was associated with higher energy intake and higher vegetable intake. Staff encouraging children to try new/less-favorite foods more than once was associated with lower fruit intake. Staff having general conversations with children (not addressed in recommendations) was associated with lower vegetable intake. Family-style meal service, staff talking about healthy foods, and staff helping children assess hunger before seconds were not significantly associated with intake. Conclusions: Few mealtime best practices were associated with dietary intake. Given the number of meals children consume in child care and the prevalence of childhood obesity, efforts to identify mealtime practices that improve children's dietary intake are crucial for obesity prevention.

27 April 2023 in Obesity Pillars
Verified
Journal Article
Open access
VOValerie O'HAra
Valerie O'HAra
SCSuzanne Cuda
Suzanne Cuda
RKRoohi Kharofa
Roohi Kharofa
MCMarisa Censani
Marisa Censani
RCRushika Conroy
Rushika Conroy
NBNancy T. Browne
Nancy T. Browne
Newer pharmacotherapy agents (anti-obesity medication [AOM]) are revolutionizing the management of children and adolescents with obesity. Previously, treatment based on intensive behavioral therapy involved many patient and family contact hours and yielded improvements in obesity status of 1-3 percent of the 95th percentile of the body mass index (BMI). Newer AOMs are yielding more clinically significant improvement of 5-18 percent. This review provides guidance for practitioners in the care of children and adolescents with obesity who frequently have complex medical and behavioral health care needs. Specifically, we discuss the use of newer AOMs in these complex patients. This review details an approach to the care of the child and adolescent with obesity using AOMs. A shared decision-making process is presented in which the provider and the patient and family collaborate on care. Management of medical and behavioral components of the disease of obesity in the child are discussed. Early aggressive treatment is recommended, starting with an assessment of associated medical and behavioral complications, weight promoting medications, use of AOMs and ongoing care. Intensive behavioral therapy is foundational to treatment, but not a specific treatment. Patients and families deserve education on expected outcomes with each therapeutic option. The use of new AOMs in children and adolescents has changed expected clinical outcomes in the field of pediatric obesity management. Clinically significant improvement in obesity status occurs when AOMs are used early and aggressively. Ongoing, chronic care is the model for optimizing outcomes using a shared decision-making between provider and patient/family. Depending on the experience and comfort level of the primary care practitioner, referral to an obesity medicine specialist may be appropriate, particularly when obesity related co-morbidities are present and pharmacotherapy and metabolic and bariatric surgery are considerations.

5 December 2022 in Obesity Pillars
Verified
Journal Article
Open access
SCSuzanne Cuda
Suzanne Cuda
MCMarisa Censani
Marisa Censani
RKRoohi Kharofa
Roohi Kharofa
VOValerie O'HAra
Valerie O'HAra
RCRushika Conroy
Rushika Conroy
NBNancy T. Browne
Nancy T. Browne
This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details medication-induced weight gain and advanced therapies for the child with overweight or obesity. The scientific information and clinical guidance in this CPS are based on scientific evidence, supported by the medical literature, and derived from the clinical perspectives of the authors. This OMA Clinical Practice Statement addresses medication-induced weight gain and advanced therapies for the child with overweight or obesity. This OMA Clinical Practice Statement on medication induced-weight gain and advanced therapies for the child with overweight or obesity is an overview of current recommendations. These recommendations provide a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications. This CPS also addresses treatment recommendations. This section is designed to help the provider with clinical decision making.

6 August 2022 in Obesity Pillars
Verified
Journal Article
Open access
SCSuzanne E. Cuda
Suzanne E. Cuda
RKRoohi Kharofa
Roohi Kharofa
DWDominique R. Williams
Dominique R. Williams
VOValerie O'HAra
Valerie O'HAra
RCRushika Conroy
Rushika Conroy
NBNancy T. Browne
Nancy T. Browne
This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details metabolic, behavioral health, and disordered eating comorbidities associated with obesity in children. This CPS will be followed by a companion CPS covering further comorbidities, including genetics and social consequences related to overweight and obesity. These CPSs are intended to provide clinicians with an overview of clinical practices applicable to children and adolescents with body mass indices greater than or equal to the 95th percentile for their ages, particularly those with adverse consequences resulting from increased body mass. The information in this CPS is based on scientific evidence, supported by the medical literature, and derived from the clinical experiences of members of the OMA. The scientific information and clinical guidance in this CPS is based upon referenced evidence and derived from the clinical perspectives of the authors. This OMA statement details metabolic, behavioral health, and disordered eating comorbidities associated with obesity in children. It provides clinical information regarding identifying and treating metabolic, behavioral health, and disordered eating comorbidities associated with obesity in children over the 95th percentile of weight/height for age. This OMA clinical practice statement details metabolic, behavioral health, and disordered eating comorbidities associated with obesity in children and provides an overview of current recommendations. These recommendations lay out a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications.

6 August 2022 in Obesity Pillars
Verified
Journal Article
Open access
SCSuzanne Cuda
Suzanne Cuda
MCMarisa Censani
Marisa Censani
RKRoohi Kharofa
Roohi Kharofa
DWDominique R. Williams
Dominique R. Williams
VOValerie O'HAra
Valerie O'HAra
NBNancy T. Browne
Nancy T. Browne
This Obesity Medicine Association (OMA) clinical practice statement (CPS) covers two topics: 1) genetics and 2) social consequences for the child with overweight and obesity. This CPS is intended to provide clinicians with an overview of clinical practices applicable to children and adolescents with body mass indices greater than or equal to the 85th percentile for their ages, particularly those with adverse consequences resulting from increased body mass. The information in this 10.13039/100008678 CPS is based on scientific evidence, supported by the medical literature, and derived from the clinical experiences of members of the 10.13039/100006091 OMA . The scientific information and clinical guidance in this CPS is based upon referenced evidence and derived from the clinical perspectives of the authors. This OMA clinical practice statement details two topics: 1) genetics and 2) social consequences for the child with overweight and obesity. This OMA clinical practice statement on genetics and social consequences for the child with overweight and obesity is an overview of current literature. The literature provides a roadmap to the improvement of the health of children and adolescents with obesity, especially those with metabolic, physiological, and psychological complications.

22 November 2016 in Clinical Pediatrics
Verified
Journal Article
Closed access
RKRoohi Kharofa
Roohi Kharofa
JKJillian A. Klein
Jillian A. Klein
PKPhilip Khoury
Philip Khoury
RSRobert M. Siegel
Robert M. Siegel
Childhood obesity rates appear to be leveling off. Studies not looking at severe obesity may be masking a rightward shift in the distribution of body mass indexes. Our objective was to provide current prevalence rates and examine trends in overweight, obesity, class 2 obesity, and class 3 obesity for youth in Cincinnati, Ohio. We performed a retrospective chart review of children 2 to 18 years old seen at Cincinnati Children’s Hospital Medical Center between July 1, 2011, and June 30, 2014. Data from 217 037 BMIs were obtained; 35.2% of children were found to have an elevated BMI. Prevalence rates were highest in older, Hispanic, and Medicaid-insured children. The only significant trend over the 3-year period was a downward shift in class 3 obesity (P = .02), contrary to national findings. Further studies assessing which clinical/community efforts have led to this downward trend will be essential to target future resources and facilitate continued progress.